Mesoporous silica nanoparticles in tissue engineering - A perspective

Nanomedicine

Volumn 11, Issue 4, 2016, Pages 391-402

  Rosenholm, Jessica Maria ^a   Zhang, Jixi ^b   Linden, Mika ^c   Sahlgren, Cecilia ^d,e  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b CHONGQING UNIVERSITY   (China)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF TURKU   (Finland)

^e EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

biosensing; controlled drug delivery; instructive biomaterials; mesoporous silica nanoparticles; regenerative therapy; stem cell imaging; stem cell microenvironment

Indexed keywords

MESOPOROUS SILICA NANOPARTICLE; BIOMATERIAL; NANOPARTICLE; SILICON DIOXIDE;

BIOCOMPATIBILITY; CELL FUNCTION; CELL TRACKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; MICROENVIRONMENT; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLD; CHEMISTRY; CYTOLOGY;

BIOCOMPATIBLE MATERIALS; NANOPARTICLES; SILICON DIOXIDE; STEM CELLS; TISSUE ENGINEERING;

EID: 84956951313     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.212     Document Type: Review

References (103)

1. Langer R, Vacanti JP. Tissue engineering. Science 260(5110), 920-926 (1993).
2. Tissue engineering. Nat. Biotechnol. 18(Suppl.), IT56-IT58 (2000).
3. Bouten CV, Driessen-Mol A, Baaijens FP. In situ heart valve tissue engineering: simple devices, smart materials, complex knowledge. Expert Rev. Med. Dev. 9(5), 453-455 (2012).
4. Sengupta D, Waldman SD, Li S. From in vitro to in situ tissue engineering. Ann. Biomed. Eng. 42(7), 1537-1545 (2014).
5. Andreas K, Sittinger M, Ringe J. Toward in situ tissue engineering: chemokine-guided stem cell recruitment. Trends Biotechnol. 32(9), 483-492 (2014).
6. Lane SW, Williams DA, Watt FM. Modulating the stem cell niche for tissue regeneration. Nat. Biotechnol. 32(8), 795-803 (2014).
7. Yang HS, Ieronimakis N, Tsui JH et al. Nanopatterned muscle cell patches for enhanced myogenesis and dystrophin expression in a mouse model of muscular dystrophy. Biomaterials 35, 1478-1486 (2014).
8. Boonen KJ, Van Der Schaft DW, Baaijens FP, Post MJ. Interaction between electrical stimulation, protein coating and matrix elasticity: A complex effect on muscle fibre maturation. J. Tissue Eng. Regen. Med. 5, 60-68 (2011).
9. Kenar H, Kose GT, Toner M, Kaplan DL, Hasirci V. A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 32, 5320-5329 (2011).
10. Chen MC, Sun YC, Chen YH. Electrically conductive nanofibers with highly oriented structures and their potential application in skeletal muscle tissue engineering. Acta Biomater. 9(3), 5562-5572 (2012).
11. Hastings CL, Roche ET, Ruiz-Hernandez E, Schenke-Layland K, Walsh CJ, Duffy GP. Drug and cell delivery for cardiac regeneration. Adv. Drug Deliv. Rev. 84, 85-106 (2015).
12. Kshitiz Park, J, Kim P et al. Control of stem cell fate and function by engineering physical microenvironments. Integr. Biol. (Camb.) 4(9), 1008-1018 (2012).
13. Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage. Nanomedicine (Lond.) 7(1), 111-120 (2012).
14. Rosenholm JM, Sahlgren C, Lindén M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. Curr. Drug Targets 12(8), 1166-1186 (2011).
15. Zhang J, Rosenholm JM. The viability of mesoporous silica nanoparticles for drug delivery. Ther. Deliv. 6(8), 891-893 (2015).
16. Mamaeva V, Sahlgren C, Lindén M. Mesoporous silica nanoparticles in medicine-recent advances. Adv. Drug Deliv. Rev. 65(5), 689-702 (2013).
17. Perez RA, El-Fiqi A, Park JH, Kim TH, Kim JH, Kim HW. Therapeutic bioactive microcarriers: co-delivery of growth factors and stem cells for bone tissue engineering. Acta Biomater. 10(1), 520-530 (2014).
18. Wang Y, Zhao Q, Han N et al. Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomed. Nanotechnol. Biol. Med. 11(2), 313-327 (2015).
19. Roggers R, Kanvinde S, Boonsith S, Oupický D. The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal. AAPS PharmSciTech 15(5), 1163-1171 (2014).
20. Hsiao J-K, Tsai C-P, Chung T-H et al. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 4(9), 1445-1452 (2008).
21. Mamaeva V, Sahlgren C, Lindén M. Mesoporous silica nanoparticles in medicine-Recent advances. Adv. Drug Deliv. Rev. 65(5), 689-702 (2013).
22. ETPN Website: Objectives/mission. www. etp-nanomedicine. eu/public/about/objectives-mission
23. Wang Y, Zhao Q, Han N et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. Adv. Drug Deliv. Rev. 65(5), 689-702 (2013).
24. He Q, Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv. Mater. 26(3), 391-411 (2014).
25. He Q, Zhang J, Chen F, Guo L, Zhu Z, Shi J. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles. Biomaterials 31(30), 7785-7796 (2010).
26. He Q, Zhang J, Shi J et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 31(6), 1085-1092 (2010).
27. Moritz M, Geszke-Moritz M. Mesoporous materials as multifunctional tools in biosciences: Principles and applications. Mater. Sci. Eng. C 49, 114-151 (2014).
28. Murugan K, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int. J. Nanomedicine 10, 2191-2206 (2015).
29. Zhang H, Dunphy DR, Jiang X et al. Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. J. Am. Chem. Soc. 134(38), 15790-15804 (2012).
30. Hudson S, Cooney J, Magner E. Proteins in mesoporous silicates. Angew. Chem. Int. Ed. Engl. 47(45), 8582-8594 (2008).
31. Shi M, Zhou Y, Shao J et al. Stimulation of osteogenesis and angiogenesis of hBMSCs by delivering Si ions and functional drug from mesoporous silica nanospheres. Acta Biomater. 21, 178-189 (2015).
32. Fan W, Shen B, Bu W et al. A smart upconversion-based mesoporous silica nanotheranostic system for synergetic chemo-/radio-/photodynamic therapy and simultaneous MR/UCL imaging. Biomaterials 35(32), 8992-9002 (2014).
33. Miller L, Winter G, Baur B et al. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET. Nanoscale 6(9), 4928-4935 (2014).
34. Chen F, Nayak TR, Goel S et al. In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles. Mol. Pharm. 11(11), 4007-4014 (2014).
35. Kumar R, Roy I, Ohulchanskky TY et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4(2), 699-708 (2010).
36. Chakravarty R, Goel S, Hong H et al. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery. Nanomedicine (Lond.) 10(8), 1233-1246 (2015).
37. Taylor KML, Kim JS, Rieter WJ, An H, Lin W, Lin W. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J. Am. Chem. Soc. 130(7), 2154-2155 (2008).
38. Hembury M, Chiappini C, Bertazzo S et al. Gold-silica quantum rattles for multimodal imaging and therapy. Proc. Natl Acad. Sci. USA 112(7), 1959-1964 (2015).
39. Shen Y, Shao Y, He H et al. Gadolinium(3+)-doped mesoporous silica nanoparticles as a potential magnetic resonance tracer for monitoring the migration of stem cells in vivo. Int. J. Nanomedicine 8, 119-127 (2013).
40. Huang D-M, Hung Y, Ko B-S et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell tracking. FASEB J. 19(14), 2014-2016 (2005).
41. Liu H-M, Wu S-H, Lu C-W et al. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. Small 4(5), 619-626 (2008).
42. Kim T, Momin E, Choi J et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adiposederived mesenchymal stem cells. J. Am. Chem. Soc. 133(9), 2955-2961 (2011).
43. Zhang L, Wang Y, Tang Y et al. High MRI performance fluorescent mesoporous silica-coated magnetic nanoparticles for tracking neural progenitor cells in an ischemic mouse model. Nanoscale 5(10), 4506-4516 (2013).
44. Kempen PJ, Greasley S, Parker KA et al. Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells. Theranostics 5(6), 631-642 (2015).
45. Jokerst J. V, Khademi C, Gambhir SS. Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation. Sci. Transl. Med. 5(177), 177ra35 (2013).
46. Gu L, Hall DJ, Qin Z et al. In vivo time-gated fluorescence imaging with biodegradable luminescent porous silicon nanoparticles. Nat. Commun. 4, 2326 (2013).
47. Yeo DC, Wiraja C, Mantalaris A, Xu C. Nanosensors for regenerative medicine. J. Biomed. Nanotechnol. 10(10), 2722-2746 (2014).
48. Choi S, Tripathi A, Singh D. Smart nanomaterials for biomedics. J. Biomed. Nanotechnol. 10(10), 3162-3188 (2014).
49. Zhao X, Kim J, Cezar CA et al. Active scaffolds for on-demand drug and cell delivery. Proc. Natl Acad. Sci. USA 108, 67-72 (2011).
50. Rosenholm JM, Sahlgren C, Linden M, Lindén M, Linden M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-opportunities & challenges. Nanoscale 2(10), 1870-1883 (2010).
51. Böcking D, Wiltschka O, Niinimäki J et al. Mesoporous silica nanoparticle-based substrates for cell directed delivery of Notch signalling modulators to control myoblast differentiation. Nanoscale 6(3), 1490-1498 (2014).
52. Hu Y, Cai K, Luo Z, Jandt KD. Layer-by-layer assembly of-estradiol loaded mesoporous silica nanoparticles on titanium substrates and its implication for bone homeostasis. Adv. Mater. 22(37), 4146-4150 (2010).
53. Mehrasa M, Asadollahi MA, Ghaedi K, Salehi H, Arpanaei A. Electrospun aligned PLGA and PLGA/gelatin nanofibers embedded with silica nanoparticles for tissue engineering. Int. J. Biol. Macromol. 79, 687-695 (2015).
54. Shi M, Zhai D, Zhao L, Wu C, Chang J. Nanosized mesoporous bioactive glass/poly(lactic-co-glycolic acid) composite-coated CaSiO3 scaffolds with multifunctional properties for bone tissue engineering. Biomed Res. Int. 2014, 323046 (2014).
55. De Matos MBC, Piedade AP, Alvarez-Lorenzo C, Concheiro A, Braga MEM, de Sousa HC. Dexamethasone-loaded poly(-caprolactone)/silica nanoparticles composites prepared by supercritical CO2 foaming/mixing and deposition nanoparticles composites prepared by supercritical CO2 foaming/mixing and deposition. Int. J. Pharm. 456(2), 269-281 (2013).
56. Singh RK, Jin G-Z, Mahapatra C, Patel KD, Chrzanowski W, Kim H-W. Mesoporous silica-layered biopolymer hybrid nanofibrous scaffold: A novel nanobiomatrix platform for therapeutics delivery and bone regeneration. ACS Appl. Mater. Interfaces 7(15), 8088-8098 (2015).
57. Alvarez GS, Echazu MIA, Olivetti CE, Desimone MF. Synthesis and characterization of ibandronate-loaded silica nanoparticles and collagen nanocomposites. Curr. Pharm. Biotechnol. 16(7), 661-667 (2015).
58. Luo Z, Deng Y, Zhang R et al. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteodifferentiation ability for bone tissue engineering. Colloids Surf. B Biointerfaces 131, 73-82 (2015).
59. Zhou X, Feng W, Qiu K et al. BMP-2 derived peptide and dexamethasone incorporated mesoporous silica nanoparticles for enhanced osteogenic differentiation of bone mesenchymal stem cells. ACS Appl. Mater. Interfaces 7(29), 15777-15789 (2015).
60. Kim T-H, Eltohamy M, Kim M et al. Therapeutic foam scaffolds incorporating biopolymer-shelled mesoporous nanospheres with growth factors. Acta Biomater. 10(6), 2612-2621 (2014).
61. Singh RK, Patel KD, Kim J-J et al. Multifunctional hybrid nanocarrier: magnetic CNTs ensheathed with mesoporous silica for drug delivery and imaging system. ACS Appl. Mater. Interfaces 6(4), 2201-2208 (2014).
62. Kim T-H, Kim M, Eltohamy M, Yun Y-R, Jang J-H, Kim HW. Efficacy of mesoporous silica nanoparticles in delivering BMP-2 plasmid DNA for in vitro osteogenic stimulation of mesenchymal stem cells. J. Biomed. Mater. Res. A 101(6), 1651-1660 (2013).
63. Song B, Wu C, Chang J. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. Acta Biomater. 8(5), 1901-1907 (2012).
64. Song B, Wu C, Chang J. Controllable delivery of hydrophilic and hydrophobic drugs from electrospun poly(lactic-coglycolic acid)/mesoporous silica nanoparticles composite mats. J. Biomed. Mater. Res. B. Appl. Biomater. 100(8), 2178-2186 (2012).
65. Kehr NS, Prasetyanto EA, Benson K, Ergün B, Galstyan A, Galla H-J. Periodic mesoporous organosilica-based nanocomposite hydrogels as three-dimensional scaffolds. Angew. Chem. Int. Ed. Engl. 52(4), 1156-1160 (2013).
66. Mamaeva V, Rosenholm JM, Bate-Eya LT et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. Mol. Ther. 19(8), 1538-1546 (2011).
67. Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling-are we there yet? Nat. Rev. Drug Discov. 13(5), 357-378 (2014).
68. Carlson ME, Connor MSO, Hsu M, Conboy IM. Notch signaling pathway and tissue engineering. 12, 5143-5156 (2007).
69. Cao Z, Ding B Sen, Guo P et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell 25(3), 350-365 (2014).
70. Landor SK-J, Mutvei AP, Mamaeva V et al. Hypo-and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc. Natl Acad. Sci. USA 108(46), 18814-18819 (2011).
71. Jin S, Hansson EM, Tikka S et al. Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Circ. Res. 102(12), 1483-1491 (2008).
72. Lee J, Kotov NA. Notch ligand presenting acellular 3D microenvironments for ex vivo human hematopoietic stemcell culture made by layer-by-layer assembly. Small 5(9), 1008-1013 (2009).
73. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16(2), 232-236 (2010).
74. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notchmediated restoration of regenerative potential to aged muscle. Science 302(5650), 1575-1577 (2003).
75. Carlson ME, Suetta C, Conboy MJ et al. Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol. Med. 1(8-9), 381-391 (2009).
76. Androutsellis-Theotokis A, Leker RR, Soldner F et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442(7104), 823-826 (2006).
77. Shokry H, Vanamo U, Wiltschka O et al. Mesoporous silica particle-PLA-PANI hybrid scaffolds for cell-directed intracellular drug delivery and tissue vascularization. Nanoscale 7(34), 14434-14443 (2015).
78. Ren M, Han Z, Li J, Feng G, Ouyang S. Ascorbic acid delivered by mesoporous silica nanoparticles induces the differentiation of human embryonic stem cells into cardiomyocytes. Mater. Sci. Eng. C 56, 348-355 (2015).
79. Shao Y, Sang J, Fu J. On human pluripotent stem cell control: the rise of 3D bioengineering and mechanobiology. Biomaterials 52, 26-43 (2015).
80. Dado D, Sagi M, Levenberg S, Zemel A. Mechanical control of stem cell differentiation. Regen. Med. 7(1), 101-116 (2012).
81. Williamson A, Singh S, Fernekorn U, Schober A. The future of the patient-specific body-on-a-chip. Lab Chip 13(18), 3471-3480 (2013).
82. Van der Meer AD, van den Berg A. Organs-on-chips: breaking the in vitro impasse. Integr. Biol. (Camb.) 4(5), 461-470 (2012).
83. El-Ali J, Sorger PK, Jensen KF. Cells on chips. Nature 442(7101), 403-411 (2006).
84. Liu J, Huang Y, Kumar A et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol. Adv. 32(4), 693-710 (2014).
85. Yuan L, Tang Q, Yang D, Zhang JZ, Zhang F, Hu J. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J. Phys. Chem. C 115(20), 9926-9932 (2011).
86. Yang K-N, Zhang C-Q, Wang W, Wang PC, Zhou J-P, Liang X-J. pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment. Cancer Biol. Med. 11(1), 34-43 (2014).
87. Théron C, Gallud A, Carcel C et al. Hybrid mesoporous silica nanoparticles with pH-operated and complementary H-bonding caps as an autonomous drug-delivery system. Chemistry 20(30), 9372-9380 (2014).
88. Zhu C-L, Wang X-W, Lin Z-Z, Xie Z-H, Wang X-R. Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles. J. Food Drug Anal. 22(1), 18-28 (2014).
89. Barkalina N, Jones C, Townley H, Coward K. Functionalization of mesoporous silica nanoparticles with a cell-penetrating peptide to target mammalian sperm in vitro. Nanomedicine (Lond.) 10(10), 1539-1553 (2015).
90. Cheng Y-J, Luo G-F, Zhu J-Y et al. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. ACS Appl. Mater. Interfaces 7(17), 9078-9087 (2015).
91. He L, Lai H, Chen T. Dual-function nanosystem for synergetic cancer chemo-/radiotherapy through ROSmediated signaling pathways. Biomaterials 51, 30-42 (2015).
92. Liu J, Zhang B, Luo Z et al. Enzyme responsive mesoporous silica nanoparticles for targeted tumor therapy in vitro and in vivo. Nanoscale 7(8), 3614-3626 (2015).
93. Xu B, Ju Y, Cui Y et al. TLyP-1-conjugated Au-nanorod@ SiO(2) core-shell nanoparticles for tumor-targeted drug delivery and photothermal therapy. Langmuir 30(26), 7789-7797 (2014).
94. Li J, Liu F, Shao Q et al. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells. Adv. Healthc. Mater. 3(8), 1230-1239 (2014).
95. Chen Y-P, Chen C-T, Hung Y et al. A new strategy for intracellular delivery of enzyme using mesoporous silica nanoparticles: superoxide dismutase. J. Am. Chem. Soc. 135(4), 1516-1523 (2013).
96. Sun J, Jakobsson E, Wang Y, Brinker C. Nanoporous silicabased protocells at multiple scales for designs of life and nanomedicine. Life 5(1), 214-229 (2015).
97. Kaehr B, Townson JL, Kalinich RM et al. Cellular complexity captured in durable silica biocomposites. Proc. Natl Acad. Sci. USA 109(43), 17336-17341 (2012).
98. Harper JC, Khirpin CY, Carnes EC et al. Cell-directed integration into three-dimensional lipid-silica nanostructured matrices. ACS Nano 4(10), 5539-5550 (2010).
99. Zhang J, Desai D, Rosenholm JM. Tethered lipid bilayer gates: toward extended retention of hydrophilic cargo in porous nanocarriers. Adv. Funct. Mater. 24(16), 2352-2360 (2014).
100. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006).
101. Murphy SV, Atala A. Organ engineering-combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantation. Bioessays 35(3), 163-172 (2013).
102. Murphy S V, Atala A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32(8), 773-785 (2014).
103. Do A-V, Khorsand B, Geary SM, Salem AK. 3D printing of scaffolds for tissue regeneration applications. Adv. Healthc. Mater. 4(12), 1742-1762 (2015).